1. Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am. 2010; 24:443–457. PMID:
20359636.
Article
2. Al Ustwani O, Ford LA, Sait SJ, et al. Myelodysplastic syndromes and autoimmune diseases-case series and review of literature. Leuk Res. 2013; 37:894–899. PMID:
23692654.
3. Komrokji RS, Kulasekararaj A, Al Ali NH, et al. Autoimmune diseases and myelodysplastic syndromes. Am J Hematol. 2016; 91:E280–E283. PMID:
26875020.
Article
4. Hagiwara A, Fujimura T, Furudate S, et al. Generalized granulomatous dermatitis accompanied by myelodysplastic syndrome. Acta Derm Venereol. 2014; 94:223–224. PMID:
23817627.
Article
5. Farah C, Bulai Livideanu C, Jegu J, et al. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome. J Eur Acad Dermatol Venereol. 2010; 24:1171–1175. PMID:
20202054.
Article
6. Avivi I, Rosenbaum H, Levy Y, Rowe J. Myelodysplastic syndrome and associated skin lesions: a review of the literature. Leuk Res. 1999; 23:323–330. PMID:
10229317.
Article
7. Tyndall A, Daikeler T. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Acta Haematol. 2005; 114:239–247. PMID:
16269864.
Article
8. Bohgaki T, Atsumi T, Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev. 2008; 7:198–203. PMID:
18190878.
Article
9. Yamanaka K, Kuniyuki S, Maekawa N, Yoshida Y, Teshima H. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation. Acta Derm Venereol. 2009; 89:105–106. PMID:
19197560.
Article
10. Haga N, Iwata H, Yamaguchi Y, et al. Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome. Br J Dermatol. 2016; 174:239–241. PMID:
26301955.
Article